Raymond Yung
Immunology and Microbiology · University of Michigan
Publications
148
Citations
9,011
Est. group size
~6
Recurring co-author estimate
Active years
34
Publishing since 1993
Typically publishes in teams of ~5 · 27% small-team papers (≤3 authors) · across 20 venues
- 405P Assessing interstitial lung disease (ILD) risk in HER2-targeting antibody-drug conjugate (HER2 ADC) therapy: A single-institution retrospective study
ESMO Open · 2025
- 363PThe role of mtDNA release as a signalling molecule in mitochondrial myopathies
Neuromuscular Disorders · 2025
- Frailty and rheumatic diseases: evidence to date and lessons learned
The Lancet Rheumatology · 2024
- Ageism and rheumatic diseases
The Lancet Rheumatology · 2024
- Palliative care in patients with rheumatic diseases
The Lancet Rheumatology · 2024
- Forecasting Four Business Cycle Phases Using Machine Learning: A Case Study of US and EuroZone
arXiv (Cornell University) · 2024
- The Influence of Variability and Uncertainty in the Clinical Reference on MRI Radiomics Modelling and Performance
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2024
- Fisetin for <scp>COVID</scp> ‐19 in skilled nursing facilities: Senolytic trials in the <scp>COVID</scp> era
Journal of the American Geriatrics Society · 2021
- Meta‐inflammaging at the crossroad of geroscience
Aging Medicine · 2019
- Immune senescence, epigenetics and autoimmunity
Clinical Immunology · 2018
- Novel role of autophagy-associated Pik3c3 gene in gonadal white adipose tissue browning in aged C57/Bl6 male mice
Aging · 2018
- Corrigendum to: Report: NIA Workshop on Measures of Physiologic Resiliencies in Human Aging
The Journals of Gerontology Series A · 2018
- Abstract LB-B16: The AKR1C3-Activated Prodrug OBI-3424 Exerts Profound <i>In Vivo</i> Efficacy Against Preclinical Models of T-Cell Acute Lymphoblastic Leukemia (T-ALL); a Pediatric Preclinical Testing Consortium Study
Molecular Cancer Therapeutics · 2018
- Abstract LB-B14: Pediatric Preclinical Testing Consortium evaluation of the second-generation selective inhibitor of nuclear export (SINE) compound KPT-8602
Molecular Cancer Therapeutics · 2018
- DIFFERENTIAL EFFECTS OF ITP LIFESPAN EXTENSION DRUGS ON ADIPOSE TISSUE INFLAMMATION IN AGING.
Europe PMC (PubMed Central) · 2018
- The Journals of Gerontology Series A×4
- Deep Blue (University of Michigan)×4
- The Lancet Rheumatology×3
- Aging×3
- AAA Foundation for Traffic Safety.×3
- Joseph Holoshitz
Immunology and Microbiology · University of Michigan
- Bruna Miglioranza Scavuzzi
Immunology and Microbiology · University of Michigan
- Mitra P. Maz
Immunology and Microbiology · University of Michigan
- Billur Akkaya
Immunology and Microbiology · The Ohio State University
- Anh Huynh
Immunology and Microbiology · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile